Shutting down RNA-targeting CRISPR.
Shutting down RNA-targeting CRISPR.
复制标题
关闭 RNA 靶向 CRISPR。
DOI:
10.1126/science.abc8243
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Sontheimer,ErikJ
中科院分区:
文献类型:
--
作者:
Barrangou,Rodolphe;Sontheimer,ErikJ
Explorations of the evolutionary arms race between bacteria and bacteriophages (viruses that infect bacteria) have unearthed a variety of defense mechanisms that include CRISPR-Cas (CRISPR-associated nuclease) adaptive immune systems (1). Understanding the mechanisms of CRISPR-mediated immunity, involving DNA-encoded, RNA-guided, sequence-specific targeting of invasive nucleic acids (2,3), has spawned powerful genome engineering platforms based on diverse Cas effectors. Subsequent studies have also revealed anti-CRISPR proteins (4) that have proven valuable as control switches for Cas molecular machines. CRISPR-Cas immune systems encompass diverse families including DNA-targeting effectors such as Cascade-Cas3, Cas9, and Cas12 as well as the recently characterized RNA-targeting Cas13 ribonuclease (RNase) (5). The evolving immune arsenal in bacteria has been matched by diverse anti-CRISPRs that enable viruses to escape Cas nuclease targeting. On page 54 of this issue, Meeskeet al.(6) report an anti-CRISPR mechanism that inhibits Cas13a RNase activity, with potential utility as a CRISPR effector control switch.